skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: A recent comment of "But we do prefer higher-growth companies" than LNTH, which companies would you be referring to?

Thanks for your service!
Read Answer Asked by Ozzie on February 26, 2024
Q: On January 9, 2024, LNTH reported preliminary Fiscal 2023 Revenue between $1.295 – $1.297B. The stock price dropped from $65.30 to around $51 over 10 days. Lantheus reported 4Q on February 22 and the stock price jumped 14.71%. 2023 Revenue was $1.3B. 2024 Revenue guidance is $1.41 - $1.445B, with Adjusted diluted EPS guidance of $6.50 - $6.70. This about 7% revenue and 4% - 7% EPS annual growth. Adjusted 4Q EPS was $1.47 beat estimate of $1.45. Using 2023 Adjusted EPS, the P/E is 9. My questions are:

1) The 14.71% price jump brought the stock price back up the level it was before January 9, 2024 announcement. I am trying to understand the market action – would you please explain or best guess?

2) In your answers to Kel question on February 7, 2024 and Neil’s question on January 9, 2024, it was mentioned LNTH growth rate has slowdown, “The company has been reinvesting heavily in the last two years to pursue growth.” The 4Q result and 2024 guidance confirm growth has slowdown. Is this a value trap? Do you think the stock price would be stagnant for awhile until growth is reestablish?

Thank you.
Read Answer Asked by Karen on February 23, 2024
Q: I am looking for new healthcare stocks after selling Lantheus and InMode in the last 6 months. I currently own WELL. Quite a few have had a good run up lately so not sure if they are good buys at current valuations. What are recommendations? US or CAD, doesn’t matter. Should I buy an ETF instead?
Thank you in advance
Read Answer Asked by Neil on January 15, 2024
Q: As you look into your crystal ball, could you please prioritize, top to bottom, your top 5 US mid cap stocks for a five year plus hold. Thanks
Read Answer Asked by Greg on December 04, 2023
Q: I sold LNTH 30 days ago to harvest the tax loss. I am looking for one more name to fill my healthcare allotment. I currently own ABBV, ISRG, WELL and SIS. Which do you like best between LNTH, DXCM and INMD, which are three names that you have been highlighting over the past several months? I am looking for potentially higher growth and am willing to take on the additional risk. Any other name(s) would certainly be welcome.

Appreciate your insight.

Paul F.
Read Answer Asked by Paul on November 27, 2023
Q: I just sold the above stocks to harvest tax losses. I intend to repurchase them in 30 days. How important (or prudent) is it, in your opinion, to purchase proxies for them? What could you recommend if your feel it is useful to do so?

Appreciate your insight.

Paul F.
Read Answer Asked by Paul on October 26, 2023
Q: Hi 5i team

I have investments in LLY and LNTH. Which among ISRG/INMD/ILMN has better potential for a 10+ year hold? and why?

Best,
Matt
Read Answer Asked by Matt on October 12, 2023
Q: From this list what would be your top 3 picks for buys right now with consideration of long term growth in TFSA? If you feel any other picks would make it in to top 3 (besides NVDA/GOOG) please include those as well.
Read Answer Asked by Theron on September 22, 2023
Q: Hi 5i,

I currently have no healthcare holdings and should be at about 9%. Could you please give me some suggested opportunities?

As always, many thanks
Read Answer Asked by ralph on September 19, 2023
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!